[1] Wang Y, Li Y, Lv L, et al. Faecal hsa-miR-7704 inhibits the growth and adhesion of Bifidobacterium longum by suppressing ProB and aggravates hepatic encephalopathy[J]. NPJ Biofilms Microbiomes, 2024, 10:13. [2] Zhu R, Liu L, Zhang G, et al. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis[J]. Biosci Rep, 2023, 43(6) :BSR20222524. [3] Tamnanloo F, Ochoa-Sanchez R, Oliveira M M, et al. Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats[J]. JHEP Rep, 2023, 5(12) : 100904. [4] Bajaj J S, Salzman N, Acharya C, et al. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis[J]. JCI Insight, 2019, 4(24) :e133410. [5] Shah Y R, Ali H, Tiwari A, et al. Role of fecal microbiota transplant in management of hepatic encephalopathy: current trends and future directions[J]. World J Hepatol, 2024, 16(1): 17-32. [6] Hassouneh R, Bajaj J S. Gut microbiota modulation and fecal transplantation: an overview on innovative strategies for hepatic encephalopathy treatment[J]. J Clin Med, 2021, 10(2) :330. [7] Jinato T, Sikaroodi M, Fagan A, et al. Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis[J]. Gut Microbes, 2023, 15(2):2288168. [8] Saboo K, Shamsaddini A, Iyer M V, et al. Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy[J]. J Hepatol, 2021, 74(1): 80-88. [9] Lu K. Cellular pathogenesis of hepatic encephalopathy: an update[J]. Biomolecules, 2023, 13(2): 396. [10] Won S-M, Oh K K, Gupta H, et al. The link between gut microbiota and hepatic encephalopathy[J]. Int J Mol Sci, 2022, 23(16): 8999. [11] Wang MW, Ma WJ, Wang Y, et al. Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota[J]. Front Microbiol, 2023, 14:1091167. [12] Yu X, Jin Y, Zhou W, et al. Rifaximin modulates the gut microbiota to prevent hepatic encephalopathy in liver cirrhosis without impacting the resistome[J]. Front Cell Infect Microbiol, 2022, 11:761192. [13] Wang Q, Chen C, Zuo S, et al. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy[J]. J Transl Med, 2023, 21: 395. [14] Ahluwalia V, Betrapally N S, Hylemon P B, et al. Impaired gut-liver-brain axis in patients with cirrhosis[J]. Sci Rep, 2016, 6: 26800. [15] Manzhalii E, Moyseyenko V, Kondratiuk V, et al. Effect of a specific escherichia coli nissle 1917 strain on minimal/mild hepatic encephalopathy treatment[J]. World J Hepatol, 2022, 14(3): 634-646. |